Your browser doesn't support javascript.
loading
Cancer care for Ukrainian refugees: Strategic impact assessments in the early days of the conflict.
Van Hemelrijck, M; Fox, L; Beyer, K; Fedaraviciute, E; George, G; Hadi, H; Haire, A; Handford, J; Mera, A; Monroy-Iglesias, M J; Moss, C L; Perdek, N; Russell, B; Santaolalla, A; Sztankay, M; Wylie, H; Jassem, J; Zubaryev, M; Anderson, B O; Ortiz, R; Ilbawi, A; Camacho, R; Ferreira-Borges, C; Roitberg, F; Dvaladze, A E; Lasierra Losada, M; Alves da Costa, F; Aggarwal, A; Lawler, M; Kopetskiy, S; Sullivan, R.
Afiliación
  • Van Hemelrijck M; Centre for Cancer, Society and Public Health, King's College London & Global Oncology Group, London, UK. Electronic address: mieke.vanhemelrijck@kcl.ac.uk.
  • Fox L; Centre for Cancer, Society and Public Health, King's College London & Global Oncology Group, London, UK. Electronic address: louis.fox@kcl.ac.uk.
  • Beyer K; Centre for Cancer, Society and Public Health, King's College London & Global Oncology Group, London, UK. Electronic address: Katharina.beyer@kcl.ac.uk.
  • Fedaraviciute E; Centre for Cancer, Society and Public Health, King's College London & Global Oncology Group, London, UK. Electronic address: egle.fedaraviciute@gmail.com.
  • George G; Centre for Cancer, Society and Public Health, King's College London & Global Oncology Group, London, UK. Electronic address: Gincy.e.george@kcl.ac.uk.
  • Hadi H; Centre for Cancer, Society and Public Health, King's College London & Global Oncology Group, London, UK. Electronic address: hajer.hadi@kcl.ac.uk.
  • Haire A; Centre for Cancer, Society and Public Health, King's College London & Global Oncology Group, London, UK. Electronic address: anna.haire@kcl.ac.uk.
  • Handford J; Centre for Cancer, Society and Public Health, King's College London & Global Oncology Group, London, UK. Electronic address: jasmine.handford@kcl.ac.uk.
  • Mera A; Centre for Cancer, Society and Public Health, King's College London & Global Oncology Group, London, UK. Electronic address: anca.mera@kcl.ac.uk.
  • Monroy-Iglesias MJ; Centre for Cancer, Society and Public Health, King's College London & Global Oncology Group, London, UK. Electronic address: maria.moroy_iglesias@kcl.ac.uk.
  • Moss CL; Centre for Cancer, Society and Public Health, King's College London & Global Oncology Group, London, UK. Electronic address: charlotte.moss@kcl.ac.uk.
  • Perdek N; Centre for Cancer, Society and Public Health, King's College London & Global Oncology Group, London, UK. Electronic address: Natalia.perdek@kcl.ac.uk.
  • Russell B; Centre for Cancer, Society and Public Health, King's College London & Global Oncology Group, London, UK. Electronic address: beth.russell@kcl.ac.uk.
  • Santaolalla A; Centre for Cancer, Society and Public Health, King's College London & Global Oncology Group, London, UK. Electronic address: aida.santaolalla@kcl.ac.uk.
  • Sztankay M; University Hospital of Psychiatry, Medical University of Innsbruck, Austria. Electronic address: monika.sztankay@tirol-kliniken.at.
  • Wylie H; Centre for Cancer, Society and Public Health, King's College London & Global Oncology Group, London, UK. Electronic address: Harriet.wylie@kcl.ac.uk.
  • Jassem J; Department of Oncology & Radiotherapy, Medical University of Gdansk Mariana Smoluchowskiego, Gdansk, Poland. Electronic address: jacek.jassem@gumed.edu.pl.
  • Zubaryev M; National Cancer Institute, Kyiv, Ukraine. Electronic address: mykola.zubaryev@gmail.com.
  • Anderson BO; World Health Organization, Geneva, Switzerland. Electronic address: andersonb@who.int.
  • Ortiz R; World Health Organization, Geneva, Switzerland. Electronic address: ortizr@who.int.
  • Ilbawi A; World Health Organization, Geneva, Switzerland. Electronic address: ilbawia@who.int.
  • Camacho R; World Health Organization, Geneva, Switzerland. Electronic address: camacho.rolando@yahoo.com.
  • Ferreira-Borges C; World Health Organization, Geneva, Switzerland. Electronic address: ferreiraborgesc@who.int.
  • Roitberg F; World Health Organization, Geneva, Switzerland. Electronic address: roitbergf@who.int.
  • Dvaladze AE; World Health Organization, Tbilisi, Georgia. Electronic address: ekberga@who.int.
  • Lasierra Losada M; World Health Organization, Tbilisi, Georgia. Electronic address: lasierram@who.int.
  • Alves da Costa F; World Health Organization, Tbilisi, Georgia. Electronic address: azevedof@who.int.
  • Aggarwal A; Centre for Cancer, Society and Public Health, King's College London & Global Oncology Group, London, UK. Electronic address: ajay.aggarwal@kcl.ac.uk.
  • Lawler M; Queen's University, Belfast, UK. Electronic address: mark.lawler@qub.ac.uk.
  • Kopetskiy S; National Cancer Institute, Kyiv, Ukraine. Electronic address: holerik@ukr.net.
  • Sullivan R; Centre for Cancer, Society and Public Health, King's College London & Global Oncology Group, London, UK. Electronic address: Richard.sullivan@kcl.ac.uk.
J Cancer Policy ; 34: 100370, 2022 12.
Article en En | MEDLINE | ID: mdl-36375808
ABSTRACT

BACKGROUND:

The invasion of Ukraine by Russia in February 2022 has resulted in destruction of healthcare infrastructure and triggered the largest wave of internally displaced populations and refugees since World War Two. Conflicts in transitioned countries such as Ukraine create new non-communicable disease (NCD) challenges, especially for cancer care for refugees and humanitarian assistance in host countries. In the early days, rapid attempts were made to model possible impacts.

METHODS:

By evaluating open source intelligence used in the first three months of the conflict through snowball search methods, we aimed to address (i) burden of cancer in Ukrainian population, specifically considering translating to the refugees population, and its cancer care capacity; ii) baseline capacity/strengths of cancer systems in initial host countries. Moreover, using a baseline scenario based on crude cancer incidence in Ukraine, and considering data from UNHCR, we estimated how cancer cases would be distributed across host countries. Finally, a surveillance assessment instrument was created, intersecting health system's capacity and influx of internally displaced populations and refugees. FINDINGS AND

CONCLUSIONS:

The total new cancer patients per month in pre-conflict Ukraine was estimated as 13,106, of which < 1 % are paediatric cases. The estimated cancer cases in the refugee population (combining prevalent and incident), assuming 7.5 million refugees by July 2022 and a femalemale ratio of 91, was 33,121 individuals (Poland 19284; Hungary 3484; Moldova 2651; Slovakia 2421; Romania 5281). According to our assessments, Poland is the only neighbouring country classified as green/yellow for cancer capacity, i.e. sufficient ablility to absorb additional burden into national health system; Slovakia we graded as yellow, Hungary and Romania as yellow/red and Moldova as red.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Refugiados / Sistemas de Socorro / Enfermedades no Transmisibles / Neoplasias Tipo de estudio: Prognostic_studies Límite: Child / Female / Humans / Male Idioma: En Revista: J Cancer Policy Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Refugiados / Sistemas de Socorro / Enfermedades no Transmisibles / Neoplasias Tipo de estudio: Prognostic_studies Límite: Child / Female / Humans / Male Idioma: En Revista: J Cancer Policy Año: 2022 Tipo del documento: Article